| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.38 | 0.003 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |